https://www.selleckchem.com/products/dnqx.html
PLAD might be a promising therapeutic strategy for the treatment of atherosclerosis and inflammation-related diseases. Long non-coding RNA (lncRNA) LINC00173 has been previously shown to promote chemoresistance and progression of small-cell lung cancer. Herein, we examine the clinical significance and biological function of LINC00173 in triple-negative breast cancer (TNBC). Quantitative PCR analysis was performed to determine the expression of LINC00173 in TNBC and adjacent breast tissues (n = 84). The associations of LINC00173 expression
Like
Comment
Share
